Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| PIMSH1 | Communication and Care Coordination | Oncology: Advance Care Planning in Metastatic Cancer Patients | Patient Engagement Experience | Registry | Details | |||
| PIMSH10 | Patient Safety | Oncology: Hepatitis B Serology Testing and Prophylactic Treatment Prior to receiving anti-CD20 targeting drugs | Process | Registry | Details | |||
| PIMSH11 | Efficiency and Cost Reduction | Oncology: Utilization of PET, PET/CT, or CT scans for Breast Cancer stage 0, I, or II at any time during the course of evaluation and treatment | Process | Registry | Details | |||
| PIMSH4 | Person and Caregiver Centered Experience and Outcomes | Oncology: Patient-Reported Pain Improvement | Outcome | Registry | Details | |||
| PIMSH8 | Effective Clinical Care | Oncology: Mutation Testing for Lung Cancer Completed Prior to Start of Targeted Therapy | Process | Registry | Details | |||
| PIMSH9 | Effective Clinical Care | Oncology: Supportive Care Drug Utilization in Last 14 Days of Life | Efficiency | Registry | Details | |||
| ONSQIR21 | Person and Caregiver Centered Experience and Outcomes | Patient Reported Health-Related Quality of Life (HRQoL) during Treatment for Advanced Cancer | Outcome | Registry | Details | |||
| ONSQIR22 | Effective Clinical Care | PCR Test with MR2 or greater result (BCR-ABL1 transcript level <= 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia | Intermediate Outcome | Registry | Details | |||
| ONSQIR23 | Effective Clinical Care | Assessment for and management of immune-related adverse events during cancer treatment with checkpoint inhibitors (ICPi) | Intermediate Outcome | Registry | Details | |||
| PINC55 | Effective Clinical Care | Appropriate Documentation of a Malnutrition Diagnosis | Process | Registry | Details | |||
| PINC56 | Effective Clinical Care | Assessment of Nutritionally At-Risk Patients for Malnutrition and Development of Nutrition Recommendations/Interventions by a Registered Dietitian Nutritionist | Process | Registry | Details | |||
| QOPI15 | Efficiency and Cost Reduction | GCSF administered to patients who received chemotherapy for metastatic cancer (Lower Score -Better) | Process | Registry | Details | |||
| QOPI23 | Effective Clinical Care | Concurrent Chemoradiation for Patients with a Diagnosis of Stage IIIB NSCLC | Process | Registry | Details | |||
| QOPI24 | Patient Safety | Hypofractionization Whole Breast Irradiation | Process | Registry | Details | |||
| QOPI25 | Patient Safety | Moderate Hypofractionization for Prostate Cancer | Process | Registry | Details | |||
| QOPI26 | Effective Clinical Care | Sentinel Lymph Node (SLN) Biopsies for Patients with AJCC T1b-T4 Melanoma | Process | Registry | Details | |||
| QOPI27 | Effective Clinical Care | Appropriate Antiemetic Therapy for High- and Moderate-Emetic Risk Antineoplastic Agents | Process | Registry | Details | |||
| QOPI5 | Efficiency and Cost Reduction | Chemotherapy administered to patients with metastatic solid tumor with performance status of ECOG 3 or 4; KPS 10 – 40; or undocumented (Lower Score - Better) | Process | Registry | Details | |||
| MEX2 | Effective Clinical Care | Heel Pain Treatment Outcomes for Pediatric Patients | Outcome | Registry | Details | |||
| MEX4 | Effective Clinical Care | Bunion Outcome - Adult and Adolescent | Outcome | Registry | Details |